During the complex lifecycle of Schistosoma mansoni, a large variety of glycans is expressed. To many of these glycans, antibodies are induced by the infected host and some might be targets for vaccines or diagnostic tests. Spatial changes in glycan expression during schistosome development are largely unexplored. To study the surface-exposed glycans during the important initial stages of infection, we analyzed the binding of a panel of anti-glycan monoclonal antibodies (mAbs) to cercariae and schistosomula up to 72 h after transformation by immunofluorescence microscopy. The mAb specificity toward their natural targets was studied using a microarray containing a wide range of schistosomal N-glycans, O-glycans and glycosphingolipid glycans. With the exception of GalNAcβ1-4(Fucα1-3)GlcNAc (LDN-F), mono-and multifucosylated GalNAcβ1-4GlcNAc (LDN)-motifs were exposed at the surface of all developmental stages studied. Multifucosylated LDN-motifs were present on cercarial glycocalyx-derived O-glycans as well as cercarial glycolipids. In contrast, the Galβ1-4(Fucα1-3)GlcNAc (Lewis X) and LDN-F-motifs, also expressed on cercarial glycolipids, and in addition on a range of cercarial N-and O-glycans, became surface expressed only after transformation of cercariae to schistosomula. In line with the documented shedding of the O-glycan-rich cercarial glycocalyx after transformation these observations suggest that surface accessible multifucosylated LDN-motifs are mostly expressed by O-glycans in cercariae, but principally by glycosphingolipids in schistosomula. We hypothesize that these temporal changes in surface exposure of glycan antigens are relevant to the interaction with the host during the initial stages of infection with schistosomes and discuss the potential of these glycan antigens as intervention targets.
Introduction
Schistosomiasis is a tropical parasitic disease with a major impact on public health in endemic areas in Africa, South-East Asia and SouthAmerica. Over 200 million people are infected with schistosomes and around 500 million people are at risk of infection (Gryseels et al. 2006) . During the complex lifecycle of Schistosoma mansoni, immature developing worms as well as adult worms are continuously in contact with components of the human lymphatic system and the blood stream. In this environment, the parasites are subject to ongoing attack by cells of the immune system (e.g. neutrophils, macrophages and eosinophils) as well as pronounced humoral responses (Butterworth and Hagan 1987) . Both larval and adult schistosomes are covered by the tegument, a syncytial cellular layer of which only the apical membrane and its glycocalyx are exposed to the host (Skelly and Allan 2006) . The tegument forms the interaction site between parasite and host and is therefore of crucial importance for successful establishment and survival of the parasite (van Hellemond et al. 2006) . The schistosome evades attacks of the host immune system by several mechanisms that involve tegument structure and function. These mechanisms include antigenic mimicry (Smithers et al. 1969; McLaren et al. 1975; Simpson et al. 1983) , rapid turnover of the tegument membranes associated with shedding of adhered host molecules and cells, (Kusel et al. 1975; Skelly and Allend 2006; van Hellemond et al. 2006 ) and proteolytic cleavage of deposited complement factors by tegumentassociated proteases . On the other hand however, the schistosome tegument provokes innate and adaptive immune responses that may lead to more effective and protective immunity. With respect to immature schistosome life stages, it has been shown that S. mansoni schistosomula tegument (SmTeg) can activate dendritic cells (DCs; Teixeira de Melo et al. 2013) and that anti-tegument antibodies are induced upon infection (Teixeira de Melo et al. 2010 Araujo et al. 2012) . In mice, vaccination with SmTeg has been shown to be partially protective against challenge with cercariae and antibodies play a major role in this protection (Teixeira de Melo et al. 2010 , 2014 . The tegument of immature schistosomula as well as adult schistosome worms contains a multitude of different proteins and glycoproteins (van Remoortere et al. 2000; Nyame et al. 2003 Nyame et al. , 2004 van Balkom et al. 2005; Wuhrer, Koeleman, Fitzpatrick et al. 2006; Castro-Borges et al. 2011 ) and because of their location and possible interactions with the immune system, these schistosomula surface-expressed molecules are receiving increasing attention as potential vaccine candidates (McWilliam et al. 2012; Reimers et al. 2015) .
In general, profound antibody responses are observed in schistosome infections, mainly against carbohydrate antigens (Nash 1978; Omer-Ali et al. 1986; Dunne 1990; Eberl et al. 2001) , and strong anti-glycan immunoglobulin M (IgM) and immunoglobulin G (IgG) responses are induced in baboons successfully vaccinated with irradiated cercariae (Kariuki et al. 2008) . Antibodies clearly play a role in protective immunity toward schistosomiasis [reviewed in van Diepen, van der Velden et al. (2012) ]. Schistosomula have been found to be sensitive to antibody-mediated cellular immune defense mechanisms of the host (Butterworth et al. 1992; Capron and Capron 1986 ) and therefore glycan antigens exposed at the tegument of developing schistosomula may hold potential as candidates for the development of a prophylactic vaccine. In vitro, it has been shown that a monoclonal antibody (mAb) against GalNAcβ1-4GlcNAc (LacDiNAc or LDN) that binds to the schistosomulum surface induces complement-mediated lysis (Nyame et al. 2003) and mAbs against the LeXmotif where capable of eosinophil-mediated killing of schistosomula (Ko et al. 1990) .
A large body of data is available concerning the expression of glycans during the schistosome life cycle (Smit et al. 2015 ) and several studies have described the expression of specific antigenic glycan motifs on the tegument and in secretions of cercariae and adult worms (Khoo et al. 1995; Nyame et al. 2000 Nyame et al. , 2003 Nyame et al. , 2004 van Remoortere et al. 2000; Thors and Linder 2003; Robijn et al. 2005; Wuhrer, Koeleman, Fitzpatrick et al. 2006; Jang-Lee et al. 2007 ). The infectious cercariae are covered by a dense glycocalyx which is shed upon transformation and which contains unique glycan elements such as Fucα1-2Fucα1-3GalNAcβ1-4(Fucα1-2Fucα1-3)GlcNAc (DF-LDN-DF) (Khoo et al. 1995) . Adult worms on the other hand seem to be much more restricted with respect to their glycan repertoire, with tegument-associated expression of GalNAcβ1-4GlcNAc (LacDiNAc or LDN) and GalNAcβ1-4(Fucα1-3)GlcNAc (LDN-F) (Wuhrer, Koeleman, Fitzpatrick et al. 2006 ). Three-day-old schistosomula express Galβ1-4(Fucα1-3)GlcNAc (Lewis X or LeX), LDN and LDN-F motifs at the tegument (Nyame et al. 2003 (Nyame et al. , 2004 Thors and Linder 2003) , but little is known about the surface expression of other glycan antigens by schistosomula.
In view of the rapid morphological and molecular changes at the schistosome surface after infection and transformation, the changes in the overall glycome of developing schistosomula, and the potential of antigenic glycans as immune-targets, we were triggered to study the surface glycosylation during the first three days of schistosomulum development. We studied the presence of glycan antigens on the surface of schistosomula and cercariae by fluorescence microscopy using antiglycan mAbs of which the fine specificity was determined using a shotgun glycan microarray constructed of the natural antigens.
Results

Immunofluorescence assays and glycan microarrays
To gain insight into S. mansoni surface glycosylation during the development of cercariae to juvenile worms, we analyzed the binding of glycan directed mAbs to the surface of cercariae and of in vitro transformed and cultured schistosomula up to 3 days old by fluorescence microscopy. The 17 different mAbs studied could be grouped according to three different binding patterns (Figure 1 ). Group 1 comprised mAbs recognizing antigenic glycan motifs covering the whole surface before and after transformation from cercariae to schistosomula, and surface expression of the motifs was sustained up to at least 3 days following transformation. Group 2 comprised mAbs binding to glycans expressed by cercariae at restricted sites, but which cover the whole surface after transformation into schistosomula. This group could be further subdivided into two groups (2A and 2B). The mAbs in group 2A bound glycans on the oral sucker of cercariae and on the whole surface of the schistosomula. The mAbs in group 2B bound to glycans on the oral sucker of cercariae, on the head or oral sucker of 3 h schistosomula and to glycans on the whole surface only in older schistosomula. Finally, group 3 contained mAbs which did not bind to any of the surface-exposed glycans of cercariae nor schistosomula. The binding patterns of all mAbs included in this study are summarized in Table I. These observations indicate that expression and/or localization of a subset of glycan antigens undergo developmental changes. The glycosylation complexity of schistosomes by far surpasses the limited variation covered by the simple, short synthetic glycoconjugates that were applied for the initial characterization of the mAbs used in this study (Khoo et al. 1995; Khoo et al. 1997a Khoo et al. , 1997b Khoo et al. , 2001 Wuhrer et al. 2000 Wuhrer et al. , 2002 Huang et al. 2001; Wuhrer, Balog et al. 2006; Wuhrer, Koeleman, Fitzpatrick et al. 2006; Hokke et al. 2007; Jang-Lee et al. 2007; Meevissen et al. 2010; Meevissen, Balog et al. 2011; Frank et al. 2012; Smit et al. 2015) . To allow a more detailed assessment of schistosomulum surface glycosylation we therefore identified the natural glycan antigens of the mAbs, using a glycan microarray composed of a large set of glycans directly isolated from schistosomes. In view of the current focus on the invading life stages we primarily evaluated the binding of mAbs to glycans derived from cercariae, but partly overlapping protein-derived glycans isolated from other life stages were also included for comparison and additional characterization of the mAbs.
Glycan specificity of group 1 mAbs
The mAbs in group 1, which bound to the whole surface of cercariae and schistosomula, reacted on the array with a wide range of Fig. 1 . Representative surface-binding patterns of mAbs in groups 1-3 by immunofluorescence microscopy of cercariae and 3, 24 and 72 h schistosomula. The mAbs in group 1 showed binding to glycans covering the whole surface of all life stages observed. Group 2A mAbs showed binding to glycans at the oral sucker of cercariae and glycans covering whole surface in later stages, while mAbs in group 2B bound glycans covering the oral sucker in cercariae, glycans covering the head and/or oral sucker in 3 h schistosomula and glycans covering the whole surface in later stages. In group 3, mAbs did not show any binding to surface glycans in any of the observed life stages. For each fluorescence image, the corresponding transmitted light ( phase-contrast) image is shown. Images of cercariae were taken with a 20× magnification, images of schistosomula were taken at 40× magnification. This Figure is Figure S1A and B). All group 1 mAbs recognized glycans with multifucosylated LDN-motifs containing the unique schistosomal Fucα1-2Fuc (DF) sequence (Table II) . The mAb 114-4D12-AA bound selectively to a limited number of printed liquid chromatography (LC)-fractions containing cercarial GSL-and O-glycans with DF motifs (Figure 2A ), whereas the other mAbs in group 1 bound to a less restricted set of glycan fractions containing DF as well as other fucosylated glycan motifs. The glycans most intensely bound by 114-4D12-AA were cercarial GSL-derived glycans that contain DF-LDN-DF-motifs (cercarial GSL-glycan fractions 19 and 21 in Table II ). The cross-reactive soluble egg antigen (SEA)-derived O-glycans with DF-LDN-DF-motifs, immunopurified using this mAb previously (Robijn, Koeleman, Wuhrer et al. 2007 ), could not be detected in our array analysis due to their very low abundance in SEA and in the SEA fractions printed. In addition, mAb 114-4D12-AA binds to the synthetic DF-GlcNAc-bovine serum albumin (BSA) conjugate (Table II) . None of the printed N-glycans were bound by mAb 114-4D12-AA (Figure 2A) . A different specificity was observed for mAb 114-5B1-A, mostly reactive with O-glycans, and slightly less with GSL-glycans of cercariae ( Figure 2B ). Most glycans found within these LC-fractions contained combinations of DF-LDN-DF, DF-LDN-TF or TF-LDN-TF (cercarial GSL-glycan fraction 35, cercarial O-glycan fractions 10.6, 11.5 and 15.6 in Table II ). However, cercarial GSL-glycans with DF-LDN-DF but without TF-motifs (e.g. cercarial GSL-glycan fractions 19 and 21) were not bound. These observations, together with the previously described affinity of 114-5B1-A for synthetic LDN-DF and TF-GlcNAc motifs which share conformational similarity of the Fucα1-2Fuc element (van Remoortere et al. 2000; van Roon et al. 2005) , therefore indicate that mAb 114-5B1-A bound to TF-motifs attached to HexNAc in O-and GSL-glycans, and LDN-DF on O-glycans. Importantly, although a relatively limited number of glycans on the array are bound by 114-4D12-AA and 114-5B1-A, their targets, DF-and TF-containing O-and/or GSL-glycans, are highly and constitutively expressed on cercariae and schistosomula (Table I) .
Four other mAbs within group 1 (258-3E3, 291-5D5-A, 128-1E7-C and 128-2C9-E) bound with high intensities to a broad range of LC-fractions containing cercarial O-and GSL-glycans, and to a selection of LC-fractions of cercarial N-glycans ( Figure 2C and D and Supplementary data, Figure S1A and B), each containing abundantly fucosylated glycans (Table II) . Especially, mAb 258-3E3 (Supplementary data, Figure S1A ) bound to almost every fucosylated glycan including structures with (multi-)fucosylated LDN-motifs, (multi-)fucosylated terminal GlcNAc-motifs and LeX-motifs. This rather broad specificity was confirmed by binding to synthetic glycoconjugates which is strongest to those that contain an α3-fucosylated GalNAc and/or GlcNAc residue (Table II) . Surprisingly, several N-glycan structures with LeX-motifs (e.g. in cercarial N-glycan fraction 26.5) were not bound by this mAb (Table II) , suggesting that some but not all LeX-motifs are bound, depending on the structural context. The mAbs 291-5D5-A and 128-1E7-C recognized many of the LC-fractions bound by mAb 258-3E3, but binding to LC-fractions comprising cercarial GSL-glycans bearing terminal LeX and DF-LDN-DF-motifs was lower or absent (cercarial GSL-glycan fractions 17, 19 and 26 in Table II ). Binding to the LeX-and DF-containing synthetic glycoconjugates was also absent, which indicates that 291-5D5-A and 128-1E7-C preferentially bind to F-LDN, LDN-F, F-LDN-F and F-GlcNAc on N-, O-and GSL-glycans but not to LeX or DF-LDN-DF. Finally for group 1, mAb 128-2C9-E bound to a specific subset of O-and GSL-glycans containing multiple Table I . Monoclonal antibodies, Ig isotype and reactivity toward the surface of cercariae and 3, 24 and 72 h schistosomula determined by immunofluorescence microscopy Table II ). The lack of binding to LC-fractions containing glycans with less DF-and TF-motifs or to any of the synthetic glycoconjugates indicates that this mAb is reactive only toward the most densely fucosylated glycan structures. In summary, multifucosylated O-and GSL-glycans together with other 
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Binding intensity of mAbs to natural glycan fractions and synthetic glycoconjugates is indicated by 1-5, where 1 is weakest binding and 5 is highest binding intensity. -, indicates that no binding was detected. a X, xylose; F, fucose; H, hexose, N, N-acetylhexosamine. b Putative structures and glycan motifs are proposed using literature-guided interpretations of the glycan compositions obtained by MALDI-TOF-MS on the basis of the references listed. Dark (blue) square, N-acetylglucosamine; light (yellow) square, N-acetylgalactosamine; medium dark (green) circle, mannose; dark (blue) circle, glucose; light (yellow) circle, galactose; dark (red) triangle, fucose; white star, xylose; AA, glycan structures presenting various forms of fucosylated LDN-and/ or GlcNAc-motifs appear to be the major glycan motifs constantly present at the surface of S. mansoni cercariae and schistosomula up to 3 days into development.
Glycan specificity of group 2A mAbs
The mAbs in group 2A which bound the oral sucker of cercariae and the whole surface after transformation into schistosomula are mainly directed toward LeX-containing cercarial N-and GSL-glycans ( Figure 2E and F, Supplementary data, Figure S1C and Table II) . For mAb 291-4D10-A ( Figure 2E ) binding to glycans that contain terminal LeX-motifs was seen in cercarial N-glycan fractions 26.5 and 28.6 and cercarial GSL-glycan fractions 17, 19, 21 and 26 (Table II) , whereas at the same time this mAb did not bind to any LC-fraction that lacked the LeX-motif. Specificity of mAb 291-4D10-A to glycans bearing LeX-motifs was further supported by the binding to all synthetic glycoconjugates of LeX, di-LeX and tri-LeX (Table II) . The other two mAbs in group 2A, 114-3A6 and 99-1G3 ( Figure 2F and Supplementary data, Figure S1C ) bound to a small subset of the LC-fractions and synthetic glycoconjugates bound by mAb 291-4D10-A (Table II) , indicating that these two mAbs have a preference for the LeX-motif in a more specific structural context. In the case of mAb 99-1G3-A, this context is defined by the observation that linear di-and trimers of LeX were bound by this mAb, whereas monomeric LeX was not bound.
Glycan specificity of group 2B mAbs
The mAbs in group 2B also bound to glycans at the oral sucker of the cercariae. In contrast to group 2A, binding to the entire surface of schistosomula was not directly observed, but only after 24 h posttransformation. Among the group 2B mAbs, 291-2G3-A bound to a subset of the same LeX-bearing cercarial GSL-glycans as the mAbs in group 2A ( Figure 2G and Table II) . Notably this mAb bound preferably to the shorter LeX-containing GSL-glycans with up to three HexNAc-residues (Table II) . Furthermore, the LeX-containing eggderived O-glycans bound by mAbs in group 2A were also bound by mAb 291-2G3-A (Table II) . However, in contrast to mAbs of group 2A, mAb 291-2G3-A did not bind to N-glycans with LeX-termini. In the case of mAb 128-4F9-A, very limited binding to cercarial LC-fractions was observed (Supplementary data, Figure S1D ), but all synthetic LeX-glycoconjugates were bound strongly (Table II) . The mAbs 290-2E6 and 114-4E8-A ( Figure 2H and Supplementary data, Figure S1E ) did not bind to cercariae-derived LC-fractions, but specific N-glycans isolated from adult worms and eggs and specific egg-derived O-glycans were recognized (worm N-glycan fraction 17.5, egg N-glycan fractions 38.3 and 39.2 and egg O-glycan fraction 36.5). These fractions contained complex mixtures of glycans with multiple different terminal motifs [e.g. fucosylated LDN in egg N-glycan fraction 38.2 and (multimeric-)LeX, LDN-F and F-GlcNAc in egg N-glycan fraction 39.2 for mAb 290-2E6; egg O-glycan fraction 36.5 for mAb 114-4E8-A (Table II) ]. Due to the complexity of the structures within these LC-fractions, it is not possible to deduce which antigenic glycan motifs are exactly recognized by these mAbs. However, based on the observation that the synthetic LDN-F-conjugate was bound very well by both 290-2E6 and 114-4E8-A (Table II) , it is most likely that within the LC-fractions that were bound by these mAb the structures that carry LDN-F motifs form the targets. N-and O-glycans presenting LDN-F motifs may therefore become surface expressed by schistosomula after 24 h development.
Glycan specificity of group 3 mAbs
Group 3 mAbs did not bind to the surface of cercariae or schistosomula. Their targets are apparently not or only minimally expressed by cercariae as none of the group 3 mAbs bound cercarial LC-fractions on the array. Binding was observed however to a specific LDN-bearing subset of N-glycans of adult worms and eggs ( Figure 2I and J) and to the worm-derived CAA and CCA glycoproteins (Supplementary data, Figure S1F and G).
In the LC-fractions most intensely bound by mAb 259-2A1 ( Figure 2I ) and mAb 273-3F2-A ( Figure 2J ), we detected glycans with terminal LDN-motifs (worm N-glycan fraction 17.5 and egg N-glycan fraction 39.2 in Table II , respectively). LDN-specificity was confirmed by high binding intensities of these mAbs toward the synthetic LDN-glycoconjugate. Interestingly, mAb 259-2A1 bound most strongly to LDN in N-glycans of adult worms and eggs, whereas 273-3F2-A only bound egg N-glycans. Furthermore, mAb 273-3F2-A bound less well to di-antennary but strongly to tri-antennary N-glycans with LDN antennae, while for mAb 259-2A1 we observed the opposite as illustrated by the binding to worm N-glycan fraction 17.5 and egg N-glycan fraction 39.2 shown in Table II . N-glycans with tri-antennary LDN are abundant in eggs as part of the egg glycoprotein kappa-5 (Meevissen, Balog et al. 2011 ), but they have not been found among the antigenic adult worm N-glycans (Smit et al. 2015; Wuhrer, Koeleman, Fitzpatrick et al. 2006) , which are dominated by mono-and di-antennary LDN.
No reactivity toward glycans at the surface of schistosomula and cercariae was observed for the anti-CAA (120-1B10-A) and anti-CCA (179-4B1-A) mAbs (Table I) , of which the natural epitope normally is present in the (developing) gut of schistosomula and adult worms (Bogers et al. 1994; Deelder et al. 1996) . These mAbs both did not bind any of the released and fractionated glycans present on the glycan microarray (Supplementary data, Figure S1F and G). For 179-4B1-A, only reactivity to tri-LeX (weak binding, Table II ) and to CCA which contains polymeric LeX glycans (strong binding, data not shown) was observed. For 120-1B10-A, we observed binding only to the immobilized CAA (strong binding, data not shown), which carries a unique GlcAβ1-3 (GlcA; glucuronic acid) substituted β1-6-linked GalNAc polymer.
Binding of mAbs to live in vitro-cultured schistosomula
For a selection of mAbs representative for each group, we determined if the surface-binding patterns observed for paraformaldehyde-fixed parasites are reproducible using live schistosomula at 3 and 48 h after transformation (Figure 3) . The mAbs 114-5B1-A and 128-1E7-C (group 1) bound to the whole surface of live schistosomula at both time points, and mAb 273-3F2-A (group 3) did not bind to the surface at all, in each case similar to the observations using fixed parasites. However, for mAb 291-4D10-A (group 2A) binding to the whole surface of live schistosomula was observed after 48 h, whereas this was already observed at 3 h for schistosomula after fixation (Figure 1 ). For mAb 290-2E6 (group 2B), no binding to the surface of the live schistosomula was observed at either time point, in contrast to fixed schistosomula which were bound moderately at 24 h and more strongly at 72 h after transformation. The accessibility of glycans recognized by these mAbs on live schistosomula thus seems to be somewhat different compared with fixed schistosomula. Possibly, paraformaldehyde allows increased binding of mAbs at earlier time points, due to crosslinking of surface components or damage to the tegument thereby supporting exposure of underlying glycans.
As outlined above, the mAbs in group 1 were directed against multifucosylated LDN and GlcNAc-motifs present on O-and/or GSL-glycans constantly present at the surface of cercariae and all schistosomula stages studied. Previously, profiling of the O-glycans of schistosomula showed that these glycans gradually disappear from the glycan spectrum after transformation, whereas expression of GSL-glycans remained (Smit et al. 2015) . Therefore, we studied the binding of the group 1 mAb 114-5B1-A to the surface of live schistosomula after 1 week in culture when O-glycan expression has subsided, to determine whether this mAb would bind to possible remaining surface-expressed GSL-glycans that contain the same motifs. Indeed, mAb 114-5B1-A was able to bind to glycans expressed at the surface of 1-week-old live schistosomula (Figure 4) , suggesting that GSL-glycans with DF-and TF-motifs attached to LDN are present at the surface in this life stage. These data suggest that the DF-and TF-motifs that were initially present in the cercarial glycocalyx O-glycans decorate the surface of 1-week-old schistosomula in the context of GSL-glycans.
Discussion
Our data show that changing sets of glycans are expressed at the surface of cercariae and developing schistosomula of S. mansoni. Glycans continuously present at the surface carried various fucosylated LDN-motifs except LDN-F, whereas glycans that appeared at the surface only after transformation possessed in addition LeX and LDN-F motifs. All of these surface-exposed antigenic glycans get into contact with the human immune system during the early stages after infection and might therefore be potential targets for intervention via antibodymediated immune mechanisms.
To be able to draw detailed conclusions about the presence, absence and localization of specific antigenic glycan motifs in the complex matrix of the schistosome surface, we first characterized in detail a set of mAbs generated against schistosome glycans using the shotgun schistosome glycan microarray. In line with previous observations indicating that LeX-expressing structures are not a uniform group in terms of antigenicity and that a wide variety of mAbs reactive toward LeX exists (Mandalasi et al. 2013; van Roon et al. 2004; van Roon 2005) , we showed that the different mAbs reactive to the LeXmotif in our study (i.e. 291-4D10-A, 114-3A6-A, 99-1G3-A, 128-4F9-A and 291-2G3-A) could be grouped based on immunofluorescence assay (Figure 1 ) and showed different binding patterns on the glycan microarray (Figure 2 and Supplementary data, Figure S1 ). For example, 291-4D10-A (group 2A) recognized LeXmotifs in a broad context of both di-and mono-antennary N-glycans, GSL-glycans and mono-and di-LeX-motifs of egg-derived O-glycans. In contrast, mAb 291-2G3-A (group 2B) only showed reactivity toward LeX-motifs on short GSL-glycans of cercariae and O-glycans of egg origin. Similar to mAbs developed by Mandalasi et al. (2013) , our mAbs exemplify a situation where a larger part of the underlying glycan structure appears to define the appropriate conformation of the specific glycan target bound. Also for mAb 114-4D12-AA, we were able to define the natural ligand more specifically. In the context of cercariae and schistosomula, 114-4D12-AA only bound to O-and GSL-glycans with DF-LDN-DF motifs. These glycans were very similar to the schistosome egg-derived O-glycans, which were previously affinity purified by mAb 114-4D12-AA (Robijn, Koeleman, ). Finally, we were able to characterize the specificity of the previously uncharacterized mAb 128-2C9-E. This mAb was reactive toward cercarial O-and GSL-glycans with a very high proportion of fucose residues, and these unique glycan motifs are expressed at cercariae and throughout the first days of schistosome development after transformation.
Group 1 mAbs, directed against fucosylated LDN-motifs expressed by O-glycans and GSL-glycans, showed intense binding to the surface of cercariae. This observation confirms the high abundance of O-glycans with fucosylated LDN-motifs in the glycocalyx of cercariae (Khoo et al. 1995) . Following transformation and associated loss of the glycocalyx, the overall O-glycan expression strongly diminishes (Hockley and McLaren 1973; Smit et al. 2015) . However, continuous binding of group 1 mAbs to the schistosomula surface was observed, for mAb 114-5B1-A even up to 1 week after transformation (Figures 1, 3 and 4 and Table I ). Since the glycan microarray showed that these antibodies also bound to fucosylated LDNcontaining GSL-glycans (Figure 2 , Supplementary data, Figure S1 and Table II) , it is likely that upon transformation when the cercarial glycocalyx and its O-glycans are lost, GSL-glycans dominate instead with respect to the exposure of antigenic glycan motifs at the schistosomula surface. Indeed, schistosome GSL-glycans carry (multi-)fucosylated LDN-motifs for at least 1 week after transformation, and these motifs are not observed on N-glycans during that time frame (Smit et al. 2015) . Possibly, GSL-glycans with fucosylated LDN-motifs are hidden underneath the cercarial surface to become exposed upon transformation after loss of the glycocalyx. Binding patterns of mAbs in group 2 which recognized N-and/or GSL-glycans carrying LeX and LDN-F motifs, but not O-glycans of the glycocalyx, support this hypothesis. Following gradual disappearance of the glycocalyx, increasingly larger patches and eventually the whole surface of schistosomula are covered by glycans that contain the LeX and LDN-F motifs. In a recent mass spectrometric (MS) study of developmental schistosome glycosylation (Smit et al. 2015) , we found that LeX and LDN-F are constantly expressed by GSL-glycans of cercariae and schistosomula for at least 1 week, further supporting the hypothesis that GSL become the main glycan antigens exposed on the schistosomula surface upon shedding of the glycocalyx. In view of the surfacebinding pattern of group 2B mAb 291-2G3-A, which binds to LeX only on GSL-glycans but not N-or O-glycans, the LeX-containing GSL-glycans and presumably also the other GSL-associated motifs become fully exposed after 24 h.
Most of the LeX-binding mAbs bound to the oral sucker of cercariae, a major site of release of cercarial secretions (Dorsey et al. 2002) . A glycomic analysis of these secreted glycoproteins has shown that these indeed abundantly express N-and O-glycans with (tandem-) LeX-motifs (Jang-Lee et al. 2007 ). Interestingly, the N-and O-glycan spectra of total cercariae were very similar to those of the cercarial secretions ; Jang-Lee et al. 2007; Khoo et al. 2001; Smit et al. 2015) . Since expression of LeX-motifs on N-glycans rapidly decreased after transformation and associated release of cercarial secretions, as does the overall O-glycan expression (Smit et al. 2015) , it appears that protein-coupled LeX antigens are mainly associated with secretions.
LDN-carrying structures were not detected at the surface of schistosomula as shown by the lack of binding of LDN-specific mAbs 259-2A1 and 273-3F2-A (Table II) , and MS analysis indicated that non-substituted LDN expression is negligible in total extracts of early schistosomula life stages (Smit et al. 2015) . In contrast, Nyame et al. (2003) described an anti-LDN mAb smLDN1.1 that bound the surface of schistosomula. This mAb was originally characterized as an antibody binding to LacdiNAc-tetraose-BSA (LDNT-BSA) that contains an LDN motif (Nyame et al. 1999) and may have a different specificity from 295-2A1 and 273-3F2-A, which bind to LDN-BSA as well as di-antennary and tri-antennary LDN N-glycans, respectively. Since smLDN1.1 binds to schistosomula and has been shown to induce lysis of the tegument in the presence of complement (Nyame et al. 2003) , it would be interesting to gain insights into the glycan structures being targeted by this antibody by means of the shotgun schistosome glycan array.
It has been hypothesized that the expression of LeX and LDN-F motifs by invading schistosomes is an adaptation of the parasite to the mammalian host environment in aid of modulation or escape of the host immune system (van Die and Cummings 2010). LeX and LDN-F motifs, in particular when present on secretory glycoconjugates, may target C-type lectin receptors on various immune cells and thereby shape the immune response (Meevissen, Yazdanbakhsh et al. 2011) . Secretory glycoproteins of the skin invading cercariae which contain many LeX-motifs (Jang-Lee et al. 2007 ) are internalized via the mannose receptor present on mononuclear phagocytic cells, leading to modulated production of pro-inflammatory cytokines and IL-4 expression in skin lymphocyte cultures (Paveley et al. 2011 ). LeX-motifs on the egg glycoprotein Omega-1 are essential for the mannose receptor-mediated internalization of this compound by DCs, which eventually leads to the Th2-priming of these DCs (Everts et al. 2012; Meevissen et al. 2010) . Furthermore, LeX-conjugates can lead to the enhanced production of anti-inflammatory interleukin-10 by macrophages and DCs (Bhargava et al. 2012) . Such immunomodulatory activities of LeX-and LDN-F- conjugates are based on the stimulation of, or interference with, lectin-mediated endogenous processes of the host immune system. The antibody responses to these motifs are however relatively low or moderate, presumably because LeX, LDN and LDN-F are not specifically parasite-associated and also occur on subsets of mammalian glycoconjugates (Naus et al. 2003; Nyame et al. 2003; van Remoortere et al. 2001 van Remoortere et al. , 2003 . Other antigenic glycan motifs that we have found to be present in particular on the surface of cercariae and schistosomula such as(DF-)LDN-DF and F-LDN-F generally induce more prominent antibody responses during schistosome infection (Naus et al. 2003; van Diepen et al. 2015; van Remoortere et al. 2001) .
From the current study, it appears that in cercariae the surface-exposed multifucosylated LDN-motifs are associated with glycocalyx O-glycans, whereas in schistosomula the surface expression of these motifs appears to be due to GSL-glycans (Smit et al. 2015 ). An important question to address will be what the functional difference is of expression of such highly antigenic motifs on proteins vs. lipids and what this may mean in terms of immunological mechanisms induced. The presence of these multifucosylated LDN-motifs in the cercarial glycocalyx might actually serve a role in misdirecting the immune system during penetration of the skin. It has been suggested that glycocalyx fragments that are shed during penetration might direct immune responses away from the invading schistosomula (Jang-Lee et al. 2007) . Alternatively, the presence of antigenic multifucosylated LDN on GSL-glycans at the surface of the schistosomula and the subsequent formation of antibodies against these structures might help vulnerable peptide-epitopes to escape the attention of the immune system (Eberl et al. 2001) . At the same time, it could however be argued that surface-exposed GSL-glycans that contain highly antigenic and specific multifucosylated DF-and TF-LDN-motifs are potential targets of a protective antibody response, in particular via mechanisms that involve antibody-dependent mechanisms of killing (van Diepen, van der Velden et al. 2012) .
In this study, we also observed that almost all mAbs reactive to the surface of cercariae and schistosomula are directed to glycans that are also expressed by schistosome eggs (Table II) . There are strong indications that antibodies cross-reactive between eggs and schistosomula are involved in blocking protective responses against schistosomula (Butterworth et al. 1988; Kariuki et al. 2008; Khalife et al. 1986 Khalife et al. , 1989 . Especially anti-carbohydrate IgM and IgG2 are associated with blocking of immunity in Schistosoma infection, although induction of effective IgG1 responses evoked to the same motifs may induce protective responses (Butterworth et al. 1988) . The type of antibodies generated in infected individuals might therefore greatly influence the development of resistance to reinfection. Glycan structures expressed at the surface of developing schistosomula might thus be potential vaccine targets depending on the type of antibody responses they induce as well as the specific structure of their antigenic motifs. All glycan motifs detected by mAbs at the surface of cercariae and schistosomula in the current study have been identified as target of the antibody response in natural infections in human populations (Nyame et al. 2000; van Remoortere et al. 2001; Naus et al. 2003; van Remoortere et al. 2003; de Boer et al. 2007; van Diepen et al. 2015) . So far, little is known however about the precise glycan structures and motifs targeted by either protective or blocking responses. Further large-scale glycan array-assisted studies of antibody profiles in sera of human schistosomiasis cohorts or experimentally infected animals may provide the essential information necessary to identify useful glycan candidates for vaccination against schistosomiasis.
Altogether, the combination of fluorescence microscopy using anti-glycan mAbs characterized by shotgun glycan microarrays provides new insights into glycan structures present on the surface of developing schistosome larvae. Our studies revealed that the glycosylation at the surface of these developmental stages is highly complex, with glycan types and motifs appearing at and disappearing from the surface over time. These data will support studies into the role of surface-exposed glycans in parasite-host interactions as well as investigations aiming at new potential glycan-targeting schistosome intervention strategies.
Materials and methods
Parasite materials
All parasite materials were derived from a Puerto Rican-strain of S. mansoni. Cercariae were shed from Biomphalaria glabrata, collected and either directly fixed with 2% paraformaldehyde or transformed in vitro. For in vitro transformation, 100,000-300,000 cercariae were centrifuged at 1600 rpm for 5 min, after which supernatant was removed and replaced by 12.5 mL of pre-warmed (37°C) Medium199 (Gibco Life Technologies, Bleiswijk, The Netherlands) supplemented with 10 mM N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid, 1× antibiotic antimycotic solution and 15 µM L-glutamine (Sigma-Aldrich, Zwijndrecht, The Netherlands). Cercariae were incubated at 37°C and 5% CO 2 for 20 min to induce transformation. Tails were separated from schistosomula bodies using an orbital shaker and schistosomula were collected and cultured for 3, 24, 48 or 72 h at 37°C and 5% CO 2 in a 24-wells plate (2000 schistosomula/mL). After the culture period, schistosomula were collected, washed and concentrated by centrifugation at 1600 rpm for 5 min before fixation with paraformaldehyde.
For immunofluorescence microscopy of live schistosomula, cercariae were transformed in vitro by passing through a double-ended syringe needle for 40 times, as previously described (Milligan and Jolly 2011) . Schistosomula were cultured for 3, 48 h or 1 week without paraformaldehyde fixation. Culture of these schistosomula was performed according to established in vitro conditions optimized for long-term culture of schistosomes (Reimers et al. 2015) . Briefly, schistosomula were cultured at 37°C and 6% CO 2 in Iscove's modified Dulbecco's medium (PAA Laboratories GmbH, Cölbe, Germany) containing 5 µg/mL insulin (Gibco Life Technologies, Darmstadt, Germany), 50 µg/mL transferrin (Sigma-Aldrich, Schnelldorf, Germany), 100 U/mL penicillin (PAA Laboratories) and 100 µg/mL streptomycin (PAA Laboratories) with 10% fetal calf serum (PAA Laboratories). After 24 h, human peripheral blood mononuclear cells (PBMC) from healthy donors were added at a concentration of 8 × 10 2 cells per µL.
After 48 h, human serum (final concentration 20%) and whole blood (final concentration 0.3%) were added. Schistosomula cultured for 3 h were not supplied with PBMC, human serum or blood. Schistosomula cultured for 48 h were not supplied with human serum or blood.
Monoclonal antibodies
Glycan-binding mAbs were produced by hybridomas generated from schistosome-infected mice or from mice immunized with schistosome extracts, as described previously (Deelder et al. 1996) . Most mAbs were partly characterized previously using surface plasmon resonance (SPR) spectroscopy using a limited range of small synthetic oligosaccharides (van Remoortere et al. 2000; van Roon et al. 2004 van Roon et al. , 2005 , or by identification of the affinity-purified target from released S. mansoni O-glycans (Robijn, Koeleman, Wuhrer et al. 2007 ). 114-4D12-AA binds to Fucα1-2Fucα1-3 (DF-motif ), 114-5B1-A to Fucα1-2Fucα1-2Fucα1-3GlcNAc (TF-GlcNAc) and to GalNAcβ1-4(Fucα1-2Fucα1-3)GlcNAc (LDN-DF), 258-3E3 to Fucα1-3-GalNAcβ1-4GlcNAc (F-LDN), Fucα1-2Fucα1-3GlcNAc (DF-GlcNAc) and TF-GlcNAc, 291-5D5-A to F-LDN, 128-1E7-C to Fucα1-3-GalNAcβ1-4(Fucα1-3)GlcNAc (F-LDN-F), 291-4D10-A to LeX, 114-3A6-A to LeX, 99-1G3-A to LeX, 128-4F9-A to LeX, 291-2G3-A to LeX, 114-4E8-A to LDN-F, 290-2E6 to LDN-F, 273-3F2-A to LDN, 259-2A1 to LDN, 120-1B10-A to glycans on CAA and 179-4B1-A to CAA and di-and trimeric LeX (Bogers et al. 1994; Deelder et al. 1996; van Remoortere et al. 2000; van Roon et al. 2004; van Roon et al. 2005; van Roon 2005; Wuhrer, Koeleman, Fitzpatrick et al. 2006; de Boer et al. 2007; Robijn, Koeleman, Wuhrer et al. 2007; Wuhrer et al. 2010 ). The mAbs 291-4D10, 114-4E8-A, 291-5D5A and 273-3F2A were in addition partially characterized previously by glycan arrays and corresponding Figure. 2C, E and J and Supplementary data, Figure S1E from the current study were constructed using the published data. 128-2C9-E was not previously characterized.
Immunofluorescence microscopy
Fixed cercariae and schistosomula were washed three times with phosphate buffered saline (PBS). Parasites were suspended in 100 µL of hybridoma culture supernatant and incubated for 30 min at 37°C followed by centrifugation (3 min at 1600 rpm) and removal of the supernatant. Parasites were washed three times with PBS and suspended in 100 µL of a 1:200 dilution of Alexa fluor 488-conjugated goat-anti-mouse IgG + IgM (Invitrogen) followed by incubation for 30 min at 37°C. Then, parasites were washed three times with PBS, transferred to a glass-slide and analyzed by fluorescence microscopy (Leica DM-RB; Leica, Rijswijk, The Netherlands). Live in vitro-cultured schistosomula were washed three times with PBS and incubated with hybridoma culture supernatant (1:50 dilution) for 1 h at room temperature. After washing with PBS, schistosomes were incubated with fluorescent-labeled goat anti-mouse IgG + IgM (Alexa fluor 488 for 3 h and 1 week schistosomula, Alexa fluor 568 for 48 h schistosomula; Invitrogen) in a 1:500 dilution for 30 min at room temperature. Schistosomula were washed with PBS, transferred to chamber slides (Ibidi, Planegg, Germany) and analyzed by fluorescence microscopy (Olympus IX; Olympus, Hamburg, Germany).
Glycan microarray construction
The construction of the glycan microarrays has been described previously (van Diepen, van Diepen et al. 2015) . In short, N-and O-glycans were released from S. mansoni cercariae, worms and eggs, and GSL-glycans were released from cercariae. Released glycans were labeled with 2-aminobenzoic acid and fractionated in two dimensions by reversed-phase high-performance LC and hydrophobic interaction LC (HILIC) as described . Two separate arrays were printed on epoxide-activated glass slides, one containing N-and GSL-glycans and one containing O-glycans.
Glycan microarray binding assays
Binding of mAbs to the glycan arrays was assayed as described previously (van Diepen, van Diepen et al. 2015) . Prior to incubation with the array, the mAb-containing supernatants were diluted 1:200 in PBS-0.01% Tween20 with 1% BSA. After washing, bound mAb was detected by incubation with either Alexa Fluor 555 goat anti-mouse IgM (Invitrogen) or Alexa Fluor 647 rabbit antimouse IgG (Invitrogen) (1:1000 diluted in PBS-0.01% Tween20 with 1% BSA), depending on the isotype of the mAb. After scanning, Genepix Pro 7.0 software was used to align and resize spots. Background-subtracted median intensity values were averaged for triplicate spots, and median values of negative controls were subtracted.
Mass spectrometry and glycan structure determination
The glycan composition of printed LC-fractions was analyzed by MALDI-TOF-MS using an Ultraflex II mass spectrometer (Bruker Daltonics, Bremen, Germany) in negative-ion reflectron mode with 2,5-dihydroxybenzoic acid (Bruker Daltonics) as matrix. Glycopeakfinder (http://glyco-peakfinder.org) was used to translate observed masses into compositions that were subsequently interpreted as putative glycan structures based on the literature and our own previously obtained structural knowledge of schistosome glycans (Khoo et al. 1995 (Khoo et al. , 1997a (Khoo et al. , 1997b Wuhrer et al. 2000; Huang et al. 2001; Wuhrer et al. 2002; Wuhrer, Balog et al. 2006; Wuhrer, Koeleman, Fitzpatrick et al. 2006; Hokke et al. 2007 ; Jang- Lee et al. 2007; Meevissen et al. 2010; Meevissen, Balog et al. 2011; Frank et al. 2012; Smit et al. 2015; van Diepen et al. 2015) .
Supplementary data
Supplementary data for this article is available online at http://glycob. oxfordjournals.org/.
